COLTENE Holding AG (LON:0QP7)
London
· Delayed Price · Currency is GBP · Price in CHF 60.80
0.00 (0.00%)
At close: Apr 22, 2025
COLTENE Holding AG Revenue
In the year 2024, COLTENE Holding AG had annual revenue of 250.16M CHF with 3.06% growth. COLTENE Holding AG had revenue of 122.66M in the half year ending December 31, 2024, a decrease of -7.21%.
Revenue
250.16M CHF
Revenue Growth
+3.06%
P/S Ratio
1.52
Revenue / Employee
199.97K CHF
Employees
1,251
Market Cap
335.76M GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 250.16M | 7.43M | 3.06% |
| Dec 31, 2023 | 242.73M | -24.40M | -9.13% |
| Dec 31, 2022 | 267.13M | -12.12M | -4.34% |
| Dec 31, 2021 | 279.24M | 30.89M | 12.44% |
| Dec 31, 2020 | 248.35M | -25.48M | -9.30% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |